67
Feng Chi Biotech Corp.
6744.TWO · TWO
$14.40 +0.00% (+$0.00)
1M -0.69%
Market Cap $221.8M
P/E Ratio 15.32x
Div. Yield 5.83%
ROE 6.14%
Bulios Fair Price
$20.93
45.3% upside
Current Price
$14.4
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 6744.TWO is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
5/9Valuation
90 /100
Cheap P/S 1.25x
P/E 15.32x
P/B 0.92x
Growth
7 /100
Declining Book val. growth 0.57%
EPS growth 16.25%
Rev. growth 2.85%
Profitability
39 /100
Moderate Op. margin 7.81%
Gross margin 44.63%
FCF margin 5.58%
Quality
33 /100
Poor ROA 5.03%
ROIC 4.82%
Asset turnover 0.62x
Debt
100 /100
Low Int. coverage 76.50x
Debt/Equity 0.02x
Net debt/EBITDA -0.46x
Stability
81 /100
Stable EPS volatility 10.06%
Beta 0.30x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 6744.TWO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Hong-Ming Zhang
Employees
32
Headquarters
Taipei